[KYMR] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -6.05%
YoY- 2.28%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 10,287 47,885 4,728 16,513 9,466 16,139 9,551 5.06%
PBT -48,557 -14,368 -52,867 -38,799 -40,928 -34,865 -43,002 8.42%
Tax 39 4,996 -895 4,632 -4,343 -818 1,916 -92.52%
NP -48,557 -14,368 -52,867 -38,799 -36,585 -34,047 -43,002 8.42%
Tax Rate - - - - - - - -
Total Cost 58,844 62,253 57,595 55,312 46,051 50,186 52,553 7.82%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -472.02 -30.01 -1,118.17 -234.96 -386.49 -210.96 -450.24 3.19%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -8.62%
EPS Diluted -0.69 -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -8.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.